Olympus (STU:OLY1) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:OLY1 Olympus Corp STU:OLY1
87 GF Score
Price €11.19
GF Value €14.68
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Olympus Net Loan?

Net Loan only applies to banks and insurance companies.

STU:OLY1
87GF Score
Olympus Corp STU:OLY1
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Olympus (STU:OLY1) Overvalued in 2026?

Based on GuruFocus' analysis, Olympus stock appears to be undervalued. The current stock price of €11.19 is trading 23.8% below its estimated GF Value™ of €14.68. GuruFocus considers Olympus to be Modestly Undervalued.

Key valuation signals for STU:OLY1:

  • Net Loan:
  • GF Value™: €14.68 vs. price of €11.19 (23.8% below fair value)
  • GF Score™: 87/100 with 6 warning signs

No single metric tells the full story. See the STU:OLY1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Olympus Business Description

Address 2951 Ishikawacho, Hachioji, JPN, 192-8507
Olympus is a medical-device maker with a leading position in the endoscope market and a diversified global revenue stream. Originally founded in 1919 in Japan as a microscope and camera maker, Olympus has gradually pivoted into endoscopic and therapeutic solutions. As of March 2025, more than 60% of its revenue comes from endoscopic solutions. In addition, North America is the biggest revenue contributor by region, accounting for 38% of its total revenue.
87GF Score

Get the complete analysis for STU:OLY1

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.19
Price
€14.68
GF Value